Neoplasms, Squamous Cell (DBCOND0033322)

Identifiers

Synonyms

Neoplasm, Squamous Cell / Squamous Cell Neoplasm / Squamous Cell Neoplasms / Squamous cell neoplasm (morphologic abnormality)

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT05839002	Primary Tumor Burden Score:A Novel Staging Parameter for ESCC After nCRT	No drug interventions	Not Available	Not Available	completed
NCT02376699	Safety Study of SEA-CD40 in Cancer Patients	Gemcitabine Paclitaxel Pembrolizumab	treatment	1	terminated
NCT05797246	Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)	Bevacizumab	treatment	2	recruiting
NCT00412776	Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer	Oportuzumab monatox	treatment	2 / 3	terminated
NCT01234480	Intended Use Study of the BD SurePath Plus™ Pap	No drug interventions	diagnostic	Not Available	terminated
NCT02526953	Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients	Capecitabine Mitomycin Paclitaxel	treatment	3	unknown_status
NCT04124198	Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma	Cisplatin Nimorazole	treatment	Not Available	recruiting
NCT05252078	Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients	APL-502 Anlotinib	treatment	2	recruiting
NCT01075841	A Post-marketing Surveillance Study on Erbitux in Combination With Platinum-based Chemotherapy in Metastatic/Recurrent Squamous Cell Cancer of the Head and Neck	Cetuximab	Not Available	Not Available	withdrawn
NCT01709448	Modeling Study to Predict Progression of Anal Cancer Pre-cursor Lesions in HIV	No drug interventions	Not Available	Not Available	unknown_status
NCT03685591	PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors	Enzalutamide	treatment	1	terminated
NCT03937791	Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions	No drug interventions	treatment	2	terminated
NCT00847912	CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial	Fluorouracil	prevention	4	completed
NCT00272181	Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer	Oportuzumab monatox	treatment	2	terminated
NCT00229723	IRESSA™ (Gefitinib) With Cisplatin Plus Radiotherapy for the Treatment of Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell Carcinoma	Cisplatin Gefitinib	treatment	2	completed